NO984445D0 - Tetrahydro-<beta>-karbolinforbindelser - Google Patents

Tetrahydro-<beta>-karbolinforbindelser

Info

Publication number
NO984445D0
NO984445D0 NO984445A NO984445A NO984445D0 NO 984445 D0 NO984445 D0 NO 984445D0 NO 984445 A NO984445 A NO 984445A NO 984445 A NO984445 A NO 984445A NO 984445 D0 NO984445 D0 NO 984445D0
Authority
NO
Norway
Prior art keywords
beta
tetrahydro
karbolinforbindelser
compounds
carboline
Prior art date
Application number
NO984445A
Other languages
English (en)
Other versions
NO984445L (no
Inventor
James E Audia
David L G Nelson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO984445D0 publication Critical patent/NO984445D0/no
Publication of NO984445L publication Critical patent/NO984445L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO984445A 1996-03-25 1998-09-24 Tetrahydro-<beta>-karbolinforbindelser NO984445L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1411996P 1996-03-25 1996-03-25
PCT/US1997/004473 WO1997035578A1 (en) 1996-03-25 1997-03-24 Tetrahydro-beta-carboline compounds

Publications (2)

Publication Number Publication Date
NO984445D0 true NO984445D0 (no) 1998-09-24
NO984445L NO984445L (no) 1998-11-20

Family

ID=21763645

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984445A NO984445L (no) 1996-03-25 1998-09-24 Tetrahydro-<beta>-karbolinforbindelser

Country Status (20)

Country Link
US (1) US5886004A (no)
EP (1) EP0942722B1 (no)
JP (1) JP2001509130A (no)
KR (1) KR20000004963A (no)
CN (1) CN1225584A (no)
AT (1) ATE267012T1 (no)
AU (1) AU714024B2 (no)
BR (1) BR9708347A (no)
CA (1) CA2248874A1 (no)
CZ (1) CZ298098A3 (no)
DE (1) DE69729211T2 (no)
EA (1) EA199800867A1 (no)
ES (1) ES2221049T3 (no)
IL (1) IL126062A0 (no)
NO (1) NO984445L (no)
NZ (1) NZ331827A (no)
PL (1) PL329212A1 (no)
TR (1) TR199801910T2 (no)
WO (1) WO1997035578A1 (no)
YU (1) YU41998A (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886003A (en) * 1996-03-25 1999-03-23 Eli Lilly And Company Methods of treating or ameliorating the symptoms of venomous bites and stings
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
AU4856600A (en) 1999-05-18 2000-12-05 Synaptic Pharmaceutical Corporation Use of agonists or antagonists of the 5-ht7 receptor to treat disorders of the bladder
US6444477B1 (en) * 2000-11-28 2002-09-03 Pharmagene Laboratories Limited Assay method for detecting 5-HT2B antagonists
DE10252667A1 (de) * 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
US20080161419A1 (en) * 2004-02-20 2008-07-03 Shinobu Akuzawa Prophylactic Antimigraine Agents
US7550499B2 (en) * 2004-05-12 2009-06-23 Bristol-Myers Squibb Company Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
MX2007008434A (es) * 2005-01-19 2007-07-25 Squibb Bristol Myers Co Derivados de 2-fenoxi-n-(1,3,4-tiadizol-2il)piridin-3-amina y compuestos relacionados como inhibidores del receptor p2y1 para el tratamiento de trastornos tromboembolicos.
WO2006085510A1 (ja) * 2005-02-08 2006-08-17 Astellas Pharma Inc. 過敏性腸症候群の治療薬
WO2007002634A1 (en) * 2005-06-27 2007-01-04 Bristol-Myers Squibb Company Carbocycle and heterocycle antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
WO2007002635A2 (en) * 2005-06-27 2007-01-04 Bristol-Myers Squibb Company C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
ES2360818T3 (es) 2005-06-27 2011-06-09 Bristol-Myers Squibb Company Miméticos de urea lineal antagonistas del receptor p2y, útiles en el tratamiento de afecciones trombóticas.
US7728008B2 (en) * 2005-06-27 2010-06-01 Bristol-Myers Squibb Company N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
CA2617473A1 (en) * 2005-08-08 2007-02-15 Astellas Pharma Inc. Acylguanidine derivative or salt thereof
US7960569B2 (en) * 2006-10-17 2011-06-14 Bristol-Myers Squibb Company Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
US9751847B2 (en) 2010-10-14 2017-09-05 University Of Utah Research Foundation Methods and compositions related to neuroactive thiazoline compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5500431A (en) * 1993-04-14 1996-03-19 Eli Lilly And Company Tetrahydro-β-carbolines
EP0749313A4 (en) * 1994-03-11 2001-10-24 Lilly Co Eli METHOD OF TREATING CONDITIONS ASSOCIATED WITH THE 5HT 2B RECEPTOR
US5663178A (en) * 1995-02-06 1997-09-02 Eli Lilly And Company Tetrahydro-beta carbolines
AU724646B2 (en) * 1996-03-15 2000-09-28 Eli Lilly And Company Method of treating common cold or allergic rhinitis
US5886003A (en) * 1996-03-25 1999-03-23 Eli Lilly And Company Methods of treating or ameliorating the symptoms of venomous bites and stings

Also Published As

Publication number Publication date
US5886004A (en) 1999-03-23
IL126062A0 (en) 1999-05-09
NZ331827A (en) 2000-02-28
WO1997035578A1 (en) 1997-10-02
BR9708347A (pt) 1999-08-03
DE69729211T2 (de) 2005-05-04
TR199801910T2 (xx) 1998-12-21
DE69729211D1 (en) 2004-06-24
CN1225584A (zh) 1999-08-11
NO984445L (no) 1998-11-20
AU2536197A (en) 1997-10-17
CA2248874A1 (en) 1997-10-02
EP0942722A1 (en) 1999-09-22
KR20000004963A (ko) 2000-01-25
CZ298098A3 (cs) 1999-02-17
EP0942722B1 (en) 2004-05-19
EA199800867A1 (ru) 1999-02-25
JP2001509130A (ja) 2001-07-10
PL329212A1 (en) 1999-03-15
EP0942722A4 (en) 2002-06-05
YU41998A (sh) 1999-07-28
ES2221049T3 (es) 2004-12-16
ATE267012T1 (de) 2004-06-15
AU714024B2 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
NO984445D0 (no) Tetrahydro-&lt;beta&gt;-karbolinforbindelser
BG102872A (en) 6-phenylpyridyl-3-amine derivatives
IL128003A0 (en) Therapeutic multispecific compounds comprised of anti-fcalpha receptor antibodies
NO990985L (no) Katalytisk blanding egnet for Fischer-Tropsch prosessen
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
DK0582385T3 (da) Reaktionssystem til fremstilling af mikrocellulære elastomerer.
IL143670A0 (en) Methods for the expression of active protein-immunoglobulin fusions, active protein-immunoglobulin fusions obtained thereby and pharmaceutical compositions containing the same
DK0874625T3 (da) Indanderivater til antipsykotiske præparater
MY106522A (en) Arylaminocarbonyl compounds.
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
DK0696278T3 (da) Herbicidtvirkende substituerede 1-phenyl- eller 1-pyridinylbenzotriazoler
MX9305998A (es) 6-heterociclic-4-amino-1, 3, 4, 5,-tetrahidrobenz[cd] indoles yprocedimiento para su preparacion.
GR3034406T3 (en) Intermediates for the preparation of 2-imidazoline-5-ones
EP0971885A4 (en) METHOD FOR PRODUCING INDAN-LIKE CONNECTIONS
WO2001012838A3 (en) Compounds which modulate the activity of an lpa receptor
TR200001969T2 (tr) 17-Değiştirilmemiş 16.beta.-ariloksi 4-azasteroidlerin sentezleri için arabileşikler ve işlem.
PT832883E (pt) Compostos de tetrahidrobenzo(a)fluoreno e metodos de uso
KR970049682U (ko) 피.시.빔용 지승의 솔 플레이트
UY24621A1 (es) Nuevos compuestos
MX9707832A (es) 1-fenil-3-pirazolcarboxilamidas que actuan sobre los receptores de neurotensina.
SU1746666A1 (ru) Замещенные 3-аминометиленпирролидин-2,4-дионы, обладающие противосудорожной активностью
MX9703752A (es) Proceso y compuestos intermedios para la preparacion de compuestos pesticidas de fluoroolefinas.
ECSP972315A (es) Procedimiento para la sintesis de benzotiofenos